Luc‐Matthieu Fornecker

2.7k total citations
37 papers, 537 citations indexed

About

Luc‐Matthieu Fornecker is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Luc‐Matthieu Fornecker has authored 37 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 19 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Luc‐Matthieu Fornecker's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Luc‐Matthieu Fornecker is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Luc‐Matthieu Fornecker collaborates with scholars based in France, Belgium and United States. Luc‐Matthieu Fornecker's co-authors include Raoul Herbrecht, Dominique Levêque, Laurent Mauvieux, Elise Toussaint, Pierre Feugier, Catherine Paillard, Lise Willems, Geneviève Ubeaud-Séquier, P. Lutun and Marie‐Sarah Dilhuydy and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Luc‐Matthieu Fornecker

31 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc‐Matthieu Fornecker France 13 263 231 109 102 84 37 537
Yi‐Hua Chen United States 11 88 0.3× 116 0.5× 128 1.2× 51 0.5× 33 0.4× 35 384
Sung‐Soo Yoon South Korea 12 67 0.3× 56 0.2× 85 0.8× 39 0.4× 133 1.6× 42 364
James A. Rybski United States 10 63 0.2× 135 0.6× 223 2.0× 114 1.1× 113 1.3× 15 574
Christina Economopoulou Greece 8 99 0.4× 88 0.4× 221 2.0× 39 0.4× 96 1.1× 15 401
Yoshiaki Okuno Japan 20 93 0.4× 43 0.2× 231 2.1× 112 1.1× 279 3.3× 41 796
Kendall W Cradic United States 11 34 0.1× 76 0.3× 203 1.9× 50 0.5× 34 0.4× 19 492
Mushtaq Ashraf Pakistan 7 131 0.5× 34 0.1× 287 2.6× 23 0.2× 163 1.9× 10 534
Matthew Clement United States 5 144 0.5× 57 0.2× 155 1.4× 193 1.9× 83 1.0× 5 467
Marina Mantzourani Greece 13 145 0.6× 17 0.1× 151 1.4× 58 0.6× 125 1.5× 48 463
Yoichiro Ogama Japan 10 34 0.1× 40 0.2× 190 1.7× 116 1.1× 72 0.9× 16 609

Countries citing papers authored by Luc‐Matthieu Fornecker

Since Specialization
Citations

This map shows the geographic impact of Luc‐Matthieu Fornecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc‐Matthieu Fornecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc‐Matthieu Fornecker more than expected).

Fields of papers citing papers by Luc‐Matthieu Fornecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc‐Matthieu Fornecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc‐Matthieu Fornecker. The network helps show where Luc‐Matthieu Fornecker may publish in the future.

Co-authorship network of co-authors of Luc‐Matthieu Fornecker

This figure shows the co-authorship network connecting the top 25 collaborators of Luc‐Matthieu Fornecker. A scholar is included among the top collaborators of Luc‐Matthieu Fornecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc‐Matthieu Fornecker. Luc‐Matthieu Fornecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Molinari, Nicolas, David Sibon, Anne‐Ségolène Cottereau, et al.. (2023). Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA. British Journal of Haematology. 202(2). 379–383.
4.
Kawka, Lou, Nicolás Meyer, Tao Ye, et al.. (2023). Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome. Arthritis & Rheumatology. 75(10). 1798–1811. 3 indexed citations
5.
Ysebaert, Loïc, Emmanuelle Ferrant, Anne‐Sophie Michallet, et al.. (2023). Outcomes of CLL Patients Exposed to Venetoclax+/-R after Ibrutinib in France: The Resist Retrospective Study from the Filo-CLL Group. Blood. 142(Supplement 1). 3273–3273. 1 indexed citations
6.
Borgne, Pierrick Le, Maleka Schenck, Jean-Étienne Herbrecht, et al.. (2022). Comparison of Short- and Long-Term Mortality in Patients with or without Cancer Admitted to the ICU for Septic Shock: A Retrospective Observational Study. Cancers. 14(13). 3196–3196. 9 indexed citations
7.
Hueso, Thomas, Thomas Gastinne, Catherine Thiéblemont, et al.. (2022). Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study. Bone Marrow Transplantation. 57(4). 627–632. 3 indexed citations
8.
Maloisel, Frédéric, et al.. (2022). Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma. Journal of Cancer Research and Clinical Oncology. 149(5). 1883–1893. 3 indexed citations
9.
Włodarska, Iwona, Olivier Gheysens, Luc Dehaspe, et al.. (2021). The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. Blood Advances. 5(7). 1991–2002. 18 indexed citations
10.
Carapito, Raphaël, Luc‐Matthieu Fornecker, Nicodème Paul, et al.. (2021). Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. Leukemia. 35(5). 1463–1474. 7 indexed citations
11.
Tavernier, Emmanuelle, Frédérique Kuhnowski, Jérôme Tamburini, et al.. (2020). Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin. Bone Marrow Transplantation. 55(9). 1834–1836. 3 indexed citations
12.
Quinquenel, Anne, Luc‐Matthieu Fornecker, Rémi Letestu, et al.. (2019). Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study. Blood. 134(7). 641–644. 88 indexed citations
13.
Noblet, Vincent, et al.. (2019). Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin’s lymphoma. Annals of Nuclear Medicine. 33(8). 564–569. 9 indexed citations
14.
Ledoux, Marie‐Pierre, Simon Gravier, Shanti Natarajan‐Amé, et al.. (2019). Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera. International Journal of Infectious Diseases. 80. 134–136. 19 indexed citations
15.
Ilias, W., Laurent Miguet, Caroline Mayeur‐Rousse, et al.. (2019). BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo. Scientific Reports. 9(1). 701–701. 26 indexed citations
16.
Deau, Bénédicte, Sandy Amorim, Aurore Perrot, et al.. (2018). Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study. British Journal of Haematology. 181(3). 341–349. 7 indexed citations
17.
Marini, Pierre De, et al.. (2016). Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions. Clinical Nuclear Medicine. 41(10). 802–803. 2 indexed citations
18.
Alhosin, Mahmoud, Antonio J. León‐González, Israa Dandache, et al.. (2015). Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. Scientific Reports. 5(1). 8996–8996. 39 indexed citations
19.
Dupuis, Jehan, Pauline Brice, Sylvie François, et al.. (2014). Ofatumumab in Refractory Chronic Lymphocytic Leukemia: Experience Through the French Early Access Program. Clinical Lymphoma Myeloma & Leukemia. 15(2). e43–e46. 10 indexed citations
20.
Nivoix, Yasmine, Guy Launoy, P. Lutun, et al.. (2012). Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. Journal of Antimicrobial Chemotherapy. 67(10). 2506–2513. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Hua Chen Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by James A. Rybski Breakdown of academic impact, for papers by Christina Economopoulou Breakdown of academic impact, for papers by Yoshiaki Okuno Breakdown of academic impact, for papers by Kendall W Cradic Breakdown of academic impact, for papers by Mushtaq Ashraf Breakdown of academic impact, for papers by Matthew Clement Breakdown of academic impact, for papers by Marina Mantzourani Breakdown of academic impact, for papers by Yoichiro Ogama
Rankless by CCL
2026